The annual summit is organized by Cleveland Clinic Innovations, the development and commercialization arm of Cleveland Clinic. The 2017 summit will highlight topics like next-generation genomic sequencing, artificial intelligence, investors’ perspectives on precision medicine and reimbursement for genomic innovation. Cleveland Clinic Innovations expects more than 2,250 healthcare leaders to attend.
“Genomics and precision medicine may hold the key to managing and eliminating some of the most debilitating diseases,” said Peter O’Neill, executive director of Cleveland Clinic Innovations. “We see a lot of activity in this market area.”
More articles on population health:
Study: Richest Americans live 10 years longer on average than poorest
How recent changes to breast screening guidelines affect physician recommendations
University of Miami Health System taps Syapse for personalized cancer care
